收费全文 | 3366985篇 |
免费 | 245307篇 |
国内免费 | 8412篇 |
耳鼻咽喉 | 45365篇 |
儿科学 | 110919篇 |
妇产科学 | 94118篇 |
基础医学 | 479238篇 |
口腔科学 | 93820篇 |
临床医学 | 310828篇 |
内科学 | 658413篇 |
皮肤病学 | 78954篇 |
神经病学 | 276023篇 |
特种医学 | 128682篇 |
外国民族医学 | 964篇 |
外科学 | 495990篇 |
综合类 | 69054篇 |
现状与发展 | 7篇 |
一般理论 | 1447篇 |
预防医学 | 266018篇 |
眼科学 | 75945篇 |
药学 | 246044篇 |
12篇 | |
中国医学 | 6467篇 |
肿瘤学 | 182396篇 |
2019年 | 26434篇 |
2018年 | 36776篇 |
2017年 | 28340篇 |
2016年 | 32421篇 |
2015年 | 36826篇 |
2014年 | 50718篇 |
2013年 | 76912篇 |
2012年 | 102324篇 |
2011年 | 108551篇 |
2010年 | 64983篇 |
2009年 | 62479篇 |
2008年 | 101925篇 |
2007年 | 108436篇 |
2006年 | 109651篇 |
2005年 | 105758篇 |
2004年 | 101795篇 |
2003年 | 98111篇 |
2002年 | 94815篇 |
2001年 | 156290篇 |
2000年 | 159945篇 |
1999年 | 135101篇 |
1998年 | 39152篇 |
1997年 | 34967篇 |
1996年 | 35423篇 |
1995年 | 34078篇 |
1994年 | 31418篇 |
1993年 | 29472篇 |
1992年 | 106242篇 |
1991年 | 103123篇 |
1990年 | 99910篇 |
1989年 | 96438篇 |
1988年 | 88940篇 |
1987年 | 87160篇 |
1986年 | 82168篇 |
1985年 | 78306篇 |
1984年 | 58899篇 |
1983年 | 50242篇 |
1982年 | 29963篇 |
1981年 | 26933篇 |
1979年 | 53026篇 |
1978年 | 37959篇 |
1977年 | 32208篇 |
1976年 | 29790篇 |
1975年 | 31901篇 |
1974年 | 38011篇 |
1973年 | 36665篇 |
1972年 | 34516篇 |
1971年 | 32089篇 |
1970年 | 29858篇 |
1969年 | 28501篇 |
Objectives
To determine: (i) the behaviour change techniques used by a sample of Australian physiotherapists to promote non-treatment physical activity; and (ii) whether those behaviour change techniques are different to the techniques used to encourage adherence to rehabilitation exercises.Design
Cross-sectional survey.Method
An online self-report survey was advertised to private practice and outpatient physiotherapists treating patients with musculoskeletal conditions. The use of 50 behaviour change techniques were measured using five-point Likert-type scale questions.Results
Four-hundred and eighty-six physiotherapists responded to the survey, with 216 surveys fully completed. Most respondents (85.1%) promoted non-treatment physical activity often or all of the time. Respondents frequently used 29 behaviour change techniques to promote non-treatment physical activity or encourage adherence to rehabilitation exercises. A similar number of behaviour change techniques was frequently used to encourage adherence to rehabilitation exercises (n = 28) and promote non-treatment physical activity (n = 26). Half of the behaviour change techniques included in the survey were frequently used for both promoting non-treatment physical activity and encouraging adherence to rehabilitation exercises (n = 25). Graded tasks was the most, and punishment was the least, frequently reported technique used to promote non-treatment physical activity and encourage adherence to rehabilitation exercises.Conclusions
Respondents reported using similar behaviour change techniques to promote non-treatment physical activity and encourage adherence to rehabilitation exercises. The variability in behaviour change technique use suggests the behaviour the physiotherapist is promoting influences their behaviour change technique choice. Including the frequently-used behaviour change techniques in non-treatment physical activity promotion interventions might improve their efficacy. 相似文献Areas covered: This article reviews the major preclinical and clinical data on PDE5 inhibitors with a specific focus on tadalafil. It includes details of the role of the nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) – PDE5 pathway in the LUT organs (bladder and prostate) in addition to the available data on tadalafil in patients with LUTS secondary to BPH with or without erectile dysfunction (ED).
Expert opinion: Preclinical and clinical data have clearly demonstrated that PDE5 inhibitors induce bladder and prostate relaxation, which contributes to the improvement seen in storage symptoms in both animal models of bladder and prostate hypercontractility. Tadalafil is effective both as a monotherapy and add-on therapy in patients with LUTS secondary to BPH. Furthermore, as LUTS-BPH and ED are urological disorders that commonly coexist in aging men, tadalafil is more advantageous than α1-adrenoceptors and should be used as the first option. Tadalafil is a safe and tolerable therapy and unlike α1- adrenoceptors and 5-alpha reductase inhibitors, which can cause sexual dysfunctions, tadalafil improves sexual function. 相似文献